CLINICAL TRIALS PROFILE FOR PREDNISOLONE ACETATE

All Clinical Trials for PREDNISOLONE ACETATE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00134992 ↗	A Study to Compare Ocular Safety and Tolerability of Prednisolone Acetate 0.5% Eye Drops Versus Vehicle in Healthy Volunteers	Completed	Novartis	Phase 4	2004-08-01	The objective of this trial was to confirm the tolerability of prednisolone acetate 0.5% eye drops by testing the hypothesis that the ocular safety and tolerability of prednisolone acetate 0.5% eye drops are equivalent to vehicle. Thus healthy volunteers have been selected and have been treated by using a crossover design.
NCT00170729 ↗	A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery	Completed	Novartis	Phase 4	2004-08-17	The primary objective was to demonstrate that two days of treatment with 0.5% prednisolone acetate eye-drops after cataract surgery are superior to vehicle in reducing the flare in the anterior chamber of the operated eye.
NCT00198523 ↗	A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte	Completed	Bausch & Lomb Incorporated	Phase 3	2005-07-01	The purpose of this study is to demonstrate the bioequivalence of the combination test agent, prednisolone acetate 1.0% and tobramycin 0.3% ophthalmic suspension compared to PredForte (prednisolone acetate 1.0%) ophthalmic suspension. Bioequivalence will be measured by comparing aqueous humor concentrations of prednisolone acetate.
NCT00229918 ↗	PST/Laser v. Laser Alone for CSME	Unknown status	Edward Hines Jr. VA Hospital	Phase 2	2005-09-01	Prospective randomized clinical trial comparing Laser Alone v. Laser and posterior sub-tenon injection of triamcinolone acetonide for primary and refractory clinically significant macular edema.
NCT00238563 ↗	Post-Operative Sub-Tenon Kenalog in Glaucoma Filtering Surgery	Withdrawn	Stanford University	N/A	1969-12-31	Determine efficacy of sub tenon kenalog injections for post-operative management of trabeculectomy procedures.
NCT00345046 ↗	A Comparison of Three Different Formulations of Prednisolone Acetate 1%	Completed	Indiana University School of Medicine	Phase 4	2002-09-01	Generic prednisolone acetate 1% is less effective than Pred Forte 1% or Econopred Plus 1%.
NCT00406042 ↗	The Role of Steroids Following Selective Laser Trabeculoplasty	Completed	West Virginia University	N/A	2005-09-01	To evaluate whether or not using topical steroids after selective laser trabeculoplasty affects intraocular pressure outcomes.

Clinical Trial Conditions for PREDNISOLONE ACETATE

Condition Name

Condition Name for PREDNISOLONE ACETATE
Intervention	Trials
Cataract	15
Glaucoma	5
Prostate Cancer	5
Prostatic Neoplasms	4

Condition MeSH

Condition MeSH for PREDNISOLONE ACETATE
Intervention	Trials
Cataract	30
Inflammation	22
Prostatic Neoplasms	16
Macular Edema	10

Clinical Trial Locations for PREDNISOLONE ACETATE

Trials by Country

Trials by Country for PREDNISOLONE ACETATE
Location	Trials
United States	222
Japan	31
Germany	23
China	22
Italy	21

Trials by US State

Trials by US State for PREDNISOLONE ACETATE
Location	Trials
New York	22
California	18
Massachusetts	12
Florida	11
Texas	11

Clinical Trial Progress for PREDNISOLONE ACETATE

Clinical Trial Phase

Clinical Trial Phase for PREDNISOLONE ACETATE
Clinical Trial Phase	Trials
Phase 4	48
Phase 3	21
Phase 2/Phase 3	7

Clinical Trial Status

Clinical Trial Status for PREDNISOLONE ACETATE
Clinical Trial Phase	Trials
Completed	49
Recruiting	27
Unknown status	7

Clinical Trial Sponsors for PREDNISOLONE ACETATE

Sponsor Name

Sponsor Name for PREDNISOLONE ACETATE
Sponsor	Trials
Ocular Therapeutix, Inc.	12
Janssen Research & Development, LLC	6
Alcon Research	5

Sponsor Type

Sponsor Type for PREDNISOLONE ACETATE
Sponsor	Trials
Other	76
Industry	62
NIH	1